End-stage Multiple System Atrophy (MSA) involves severe autonomic failure and motor decline, with major signs including profound difficulty swallowing (dysphagia), speech loss (dysarthria), significant breathing issues (sleep apnea, stridor), constant falls, inability to move (bedridden), and requiring total care, often leading to death from complications like infections (pneumonia) or respiratory failure.
Appetite reduces and weight loss is apparent. Communication becomes too effortful and breathing more bubbly or shallow. Dying is a natural process where our bodily functions all slow down and ultimately stop. This will be a very emotional time for everyone close to the dying person.
Multiple system atrophy (MSA) is a rare neurological disease that causes certain brain areas to deteriorate. Over time, this disrupts abilities and functions handled by those brain areas. This disease is ultimately fatal.
People typically live about 7 to 10 years after multiple system atrophy symptoms first appear. However, the survival rate with MSA varies widely. Death is often due to trouble breathing, infections or blood clots in the lungs.
Symptoms tend to appear in a person's 50s and advance rapidly over the course of five to 10 years. A person with MSA will have increased difficulty with movement and eventually become bedridden. People with MSA often develop swallowing problems that can lead to pneumonia in the later stages of the disease.
The disease tends to progress rapidly. About one half of people with MSA-P have lost most of their motor skills within 5 years of onset of the disease. Symptoms may include: Passing out (syncope) due to drops in blood pressure.
Respiratory symptoms, including stridor, sleep-disordered breathing, and respiratory insufficiency, are known to additionally occur in MSA,1-3 although these are not included in the consensus diagnostic criteria.
In people with MSA, nerves in the area of the brain that controls things like balance and movement become damaged and lost over time. It's not known why this happens. There's no evidence that it can be passed on to children by their parents (inherited).
Prevalence of Pain in MSA
Pooling the results of all studies included in the quantitative analysis, 761 of the 1236 individuals with MSA complained about pain, with a prevalence range of 40% to 88% and an estimated pooled prevalence of 67% (95% CI = 57%–75%) (Fig. 2).
MSA is a terminal disease with an average patient survival of 6 to 10 years after the onset of symptoms.
Clinicians should be aware that the following features may be 'red flags', or warning signs, of MSA-P: early instability, rapid progression, abnormal postures, bulbar dysfunction, respiratory dysfunction, and emotional incontinence.
Termination for non-renewal refers to the expiration of the MSA at the end of its fixed term if the parties do not agree to renew the agreement. If the MSA has a fixed term and is not renewed by the parties, it will be terminated upon expiration.
Mild cognitive impairment has been reported in up to 40 % of MSA patients6, 14 and can also occur in early stage of disease. Nonetheless, severe cognitive decline that significantly disrupts daily living is uncommon in MSA.
In Parkinsons disease and multiple system atrophy (MSA), cardiovascular dysfunction may occur for a variety of reasons and may manifest itself through inappropriate changes and/or levels in blood pressure, heart rate and/or regional vascular perfusion in a range of situations.
Offer to do the shopping. Help with everyday tasks round the house such as hanging the washing out, doing the hoovering etc. Share your computer and technology skills with them, these can be a lifeline for people with MSA but they may need help learning to use them.
Anxiety, agitation, apathy, impulse control disorders, and REM sleep behavioral disorder (RBD) are the most common behavioral changes in MSA [13,14,15]. Obsessive compulsive disorders (OCD) may also occur, but these are less common [16].
Most commonly people with MSA experience increasing sluggishness of the bowel and risk a build-up of chronic constipation. You should aim to keep your bowel movements at least as regular as they were before you had MSA.
This instability can affect the legs, leading to difficulties with walking and increasing the risk of falls. Gait abnormalities: Changes in gait, including a shuffling or hesitant walk, reduced stride length and difficulty initiating movement are common with multiple system atrophy.
Medicines that treat Parkinson's disease, such as combined levodopa and carbidopa (Sinemet, Duopa, others), can help some people with MSA. The medicine can treat stiffness, trouble with balance and slow movements.
Patients with MSA may present with cerebellar or parkinsonism predominant phenotypes. Ocular symptoms include dry eye, saccadic abnormalities, and cerebellar nystagmus. There is no proven effective treatment for MSA and the prognosis is poor.
Indeed, a patient with MSA may present with vocal fold paralysis, and respiratory distress may be the initial symptom. Vocal fold paralysis may go unrecognized, as it presents insidiously and patients may develop some tolerance during its initial progression.
People living with MSA may experience periods of low mood, depression and/or anxiety, yet mental health is often overlooked at routine appointments with health and care professionals. Being able to recognise how MSA is affecting your mental health can help you to seek professional support when needed.
The symptoms of respiratory failure depend on the cause and the levels of oxygen and carbon dioxide in your blood. A low oxygen level in the blood can cause shortness of breath and air hunger (the feeling that you can't breathe in enough air). Your skin, lips, and fingernails may also have a bluish color.
Parkinson's patients are prone to low blood pressure, so hydration is especially important. Make sure that you drink at least 6-8 glasses of water a day (unless you have cardiac problems) and have a glass of water before you take your morning PD medications.
Impairment of the nerve co-ordination of the bladder, preventing proper emptying of the bladder, is common in MSA. This can be one of the main reasons why people with MSA are so susceptible to getting urinary tract infections (UTI's).